Most recent guideline publication:
Updates since publication:
None
Tables provided in the main manuscript of the guideline:
| Table 1. Assignment of predicted phenotypes based on diplotypes |
| Table 2. Dosing recommendations for antidepressants based on CYP2D6 phenotype |
| Table 3. Dosing recommendations for antidepressants based on CYP2C19 phenotype |
Tables and figures included in the supplementa or referenced in the guideline:
| Table S1. Evidence linking CYP2D6, CYP2C19 and CYP2B6 genotype to SSRI phenotype |
| Table S2. Evidence linking CYP2D6 genotype to SNRI and serotonin modulator phenotype |
| Table S3. Evidence linking SLC6A4 genotype to antidepressant phenotype |
| Table S4. Evidence linking HTR2A genotype to antidepressant phenotype |
| Table S5. Metabolism of antidepressants included in this guideline. |
| Table S6. Dosing Recommendation for fluoxetine based on CYP2D6 phenotype |
| Table S7. Dosing recommendations for citalopram and escitalopram based on HTR2A genotype |
| Table S8. Dosing recommendations for fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran and milnacipran based on HTR2A genotype |
| Table S9. Dosing recommendations citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran and milnacipran based on SLC6A4 genotype |
| Table S10. Meta-analyses of evidence linking genetic variation to antidepressant phenotypes |
| CYP2D6 allele definition table CYP2C19 allele definition table CYP2B6 allele definition table |
| CYP2D6 allele functionality table CYP2C19 allele functionality table CYP2B6 allele functionality table |
| CYP2D6 frequency table CYP2C19 frequency table CYP2B6 frequency table |
| CYP2D6 diplotype-phenotype table CYP2C19 diplotype-phenotype table CYP2B6 diplotype-phenotype table |
| Gene resource mappings CYP2D6 CYP2C19 CYP2B6 |
| Drug Resource mappings Citalopram Escitalopram Fluvoxamine Paroxetine Sertraline Venlafaxine Vortioxetine |
| Clinical decision support:b Implementation workflow CYP2D6 consult CYP2C19 consult CYP2B6 consult Citalopram pre- and post-test alerts and workflow Escitalopram pre- and post-test alerts and workflow Fluvoxamine pre- and post-test alerts and workflow Paroxetine pre- and post-test alerts and workflow Sertraline pre- and post-test alerts and workflow Venlafaxine pre- and post-test alerts and workflow Vortioxetine pre- and post-test alerts and workflow |
bThese resources support the adoption of CPIC guidelines into the electronic health record with clinical decision support and provide information that clinical implementers find helpful.